COMPANY

STADA Arzneimittel AG

Name: STADA Arzneimittel AG peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

STADA Arzneimittel AG: marketing authorisation holder for Liraglutide, Teriparatide, as stated by public registers.

Also written as: STADA ARZNEIMITTEL AG.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

Liraglutide	Ablymico (EMEA/H/C/006620), Authorised Regulator EMA
Liraglutide	Liraglutide STADA (EMEA/H/C/006615), Authorised Regulator EMA
Teriparatide	Movymia (EMEA/H/C/004368), Authorised Regulator EMA
Teriparatide	MOVYMIA 20 MICROGRAMS/80 MICROLITERS SOLUTION FOR INJECTION, PLGB 11204/0337, Authorised Regulator MHRA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.